Keyphrases
Adult Patients
100%
Non-alcoholic Fatty Liver Disease (NAFLD)
100%
30-day Mortality
100%
Community-acquired Pneumonia
100%
Body Mass Index
18%
C-reactive Protein
18%
CURB-65
18%
Advanced Fibrosis
18%
Risk Factors
9%
Type 2 Diabetes Mellitus (T2DM)
9%
Obesity
9%
Comorbidity
9%
Hospitalized Patients
9%
Liver Enzymes
9%
All-cause Mortality
9%
Retrospective Cohort Study
9%
Disease Groups
9%
Chronic Liver Disease
9%
Fibrosis Score
9%
Abdominal Ultrasonography
9%
Pneumonia Severity Index
9%
Medicine and Dentistry
Nonalcoholic Fatty Liver
100%
All Cause Mortality
100%
Community-Acquired Pneumonia
100%
Body Mass Index
18%
Fibrosis
18%
C Reactive Protein
18%
Prevalence
9%
Infection
9%
Maturity Onset Diabetes of the Young
9%
Liver Enzyme
9%
Mortality Rate
9%
Retrospective Cohort Study
9%
Chronic Liver Disease
9%
Liver Fibrosis
9%
Abdominal Ultrasonography
9%
Pneumonia Severity Index
9%
Pharmacology, Toxicology and Pharmaceutical Science
Nonalcoholic Fatty Liver
100%
All Cause Mortality
100%
Community Acquired Pneumonia
100%
C Reactive Protein
18%
Fibrosis
18%
Non Insulin Dependent Diabetes Mellitus
9%
Cohort Study
9%
Infection
9%
Chronic Liver Disease
9%
Comorbidity
9%
Liver Enzyme
9%
Prevalence
9%
Mortality Rate
9%
Liver Fibrosis
9%